Xu X J, Hao J X, Wiesenfeld-Hallin Z
Department of Medical Laboratory Sciences and Technology, Karolinska Institute, Huddinge University Hospital, Sweden.
Neuroreport. 1996 Sep 2;7(13):2092-4.
A heptadecapeptide (orphanin FQ or nociceptin) was recently identified as an endogenous ligand for the orphan opioid-like receptor. Here we report that intrathecal orphanin FQ produces dose-dependent depression of a spinal nociceptive flexor reflex in the rat. Furthermore, administration of orphanin FQ in rats with intrathecal catheters produced behavioural antinociception in the tail flick test with no signs of sedation or motor impairment. The reflex depressive effect of orphanin FQ was not reversed by antagonists of opioidergic, alpha 2-adrenergic and GABA-A receptors. Thus, orphanin FQ may suppress nociceptive input at the spinal level through an novel mechanism. Orphanin FQ or agonists of its receptor may represent novel analgesics for pain conditions which are not responsive to existing pharmacological therapy.
一种十七肽(孤啡肽FQ或痛敏肽)最近被鉴定为类阿片孤儿受体的内源性配体。在此我们报告,鞘内注射孤啡肽FQ可使大鼠脊髓伤害性屈肌反射产生剂量依赖性抑制。此外,给有鞘内导管的大鼠注射孤啡肽FQ,在甩尾试验中产生行为性抗伤害感受,且无镇静或运动障碍迹象。孤啡肽FQ的反射抑制作用不能被阿片能、α2-肾上腺素能和GABAA受体拮抗剂逆转。因此,孤啡肽FQ可能通过一种新机制在脊髓水平抑制伤害性传入。孤啡肽FQ或其受体激动剂可能代表对现有药物治疗无反应的疼痛状况的新型镇痛药。